|
1
|
National Cancer Institute. Cancer
statistics: SEER stat fact sheets. Hodgkin lymphoma. http://seer.cancer.gov/statfacts/html/hodg.html.
Accessed October, 2013
|
|
2
|
Bonadonna G, Zucali R, Monfardini S, et
al: Combination chemotherapy of Hodgkin’s disease with adriamycin,
bleomycin, vinblastine and imidazole carboxamide versus MOPP.
Cancer. 36:252–259. 1975. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Canellos GP and Niedzwiecki D: Long-term
follow-up of Hodgkin’s disease trial. N Engl J Med. 346:1417–1418.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Borchmann P and Engert A: The past: what
we have learned in the last decade. Hematology Am Soc Hematol Educ
Program. 2010:101–107. 2010. View Article : Google Scholar
|
|
5
|
Chiaravalloti A, Pagani M, Di Pietro B, et
al: Is cerebral glucose metabolism affected by chemotherapy in
patients with Hodgkin’s lymphoma? Nucl Med Commun. 34:57–63. 2012.
View Article : Google Scholar
|
|
6
|
Pasquini M and Biondi M: Depression in
cancer patients: a critical review. Clin Pract Epidemiol Ment
Health. 3:22007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Spiegel D: Health care. Psychosocial
support for patients with cancer. Cancer. 74(Suppl 4): 1453–1457.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ospedale Santa Croce-Carle Cuneo. Positron
Emission Tomography (PET) - Adapted Chemotherapy In Advanced
Hodgkin Lymphoma (HL) (HD0607). NLM identifier: NCT00795613.
http://clinicaltrials.gov/show/NCT00795613.
Accessed October 2010
|
|
9
|
Varrone A, Asenbaum S, Vander Borght T, et
al; European Association of Nuclear Medicine Neuroimaging
Committee. EANM procedure guidelines for PET brain imaging using
[18F]FDG, version 2. Eur J Nucl Med Mol Imaging. 36:2103–2110.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lister TA, Crowther D, Sutcliffe SB, et
al: Report of a committee convened to discuss the evaluation and
staging of patients with Hodgkin’s disease: Cotswolds meeting. J
Clin Oncol. 7:1630–1636. 1989.PubMed/NCBI
|
|
11
|
Gallamini A, Fiore F, Sorasio R and
Meignan M: Interim positron emission tomography scan in Hodgkin
lymphoma: definitions, interpretation rules, and clinical
validation. Leuk Lymphoma. 50:1761–1764. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gallamini A, Hutchings M, Rigacci L, et
al: Early interim 2-[18F]fluoro-2-deoxy-D-glucose
positron emission tomography is prognostically superior to
international prognostic score in advanced-stage Hodgkin’s
lymphoma: a report from a joint Italian-Danish study. J Clin Oncol.
25:3746–3752. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gallamini A, Rigacci L, Merli F, et al:
The predictive value of positron emission tomography scanning
performed after two courses of standard therapy on treatment
outcome in advanced stage Hodgkin’s disease. Haematologica.
91:475–481. 2006.PubMed/NCBI
|
|
14
|
Cistaro A, Valentini MC, Chiò A, et al:
Brain hypermetabolism in amyotrophic lateral sclerosis: a FDG PET
study in ALS of spinal and bulbar onset. Eur J Nuc Med Mol Imaging.
39:251–259. 2011. View Article : Google Scholar
|
|
15
|
Bennett CM, Wolford GL and Miller MB: The
principled control of false 483 positives in neuroimaging. Soc Cogn
Affect Neurosci. 4:417–422. 2009. View Article : Google Scholar
|
|
16
|
Janelsins MC, Roscoe JA, Berg MJ, et al:
IGF-1 partially restores chemotherapy-induced reductions in neural
cell proliferation in adult C57BL/6 mice. Cancer Invest.
28:544–553. 2010. View Article : Google Scholar
|
|
17
|
Lopes MA, Meisel A, Dirnagl U, et al:
Doxorubicin induces biphasic neurotoxicity to rat cortical neurons.
Neurotoxicology. 29:286–293. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Attwell D and Laughlin SB: An energy
budget for signaling in the grey matter of the brain. J Cereb Blood
Flow Metab. 21:1133–1145. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zimmer P, Mierau A, Bloch W, et al:
Post-chemotherapy cognitive impairment in patients with B-cell
non-Hodgkin lymphoma: a first comprehensive approach to determine
cognitive impairments after treatment with rituximab,
cyclophosphamide, doxorubicin, vincristine and prednisone or
rituximab and bendamustine. Leuk Lymphoma. 1–6. 2014. View Article : Google Scholar
|
|
20
|
Bruno J, Hosseini SM and Kesler S: Altered
resting state functional brain network topology in
chemotherapy-treated breast cancer survivors. Neurobiol Dis.
48:329–338. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Silverman DH, Dy CJ, Castellon SA, et al:
Altered frontocortical, cerebellar, and basal ganglia activity in
adjuvant-treated breast cancer survivors 5–10 years after
chemotherapy. Breast Cancer Res Treat. 103:303–311. 2007.
View Article : Google Scholar
|
|
22
|
Barton MK: Cognitive deficits are usually
mild in patients with breast cancer after chemotherapy. CA Cancer J
Clin. 63:3–4. 2013. View Article : Google Scholar
|
|
23
|
Hakamata Y, Matsuoka Y, Inagaki M, et al:
Structure of orbitofrontal cortex and its longitudinal course in
cancer-related post-traumatic stress disorder. Neurosci Res.
59:383–389. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Niida A, Niida R, Matsuda H, Inada T,
Motomura M and Uechi A: Identification of atrophy of the subgenual
anterior cingulate cortex, in particular the subcallosal area, as
an effective auxiliary means of diagnosis for major depressive
disorder. Int J Gen Med. 5:667–674. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bonne O, Gilboa A, Louzoun Y, et al:
Resting regional cerebral perfusion in recent posttraumatic stress
disorder. Biol Psychiatry. 54:1077–1086. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sachinvala N, Kling A, Suffin S, et al:
Increased regional cerebral perfusion by 99mTc hexamethyl propylene
amine oxime single photon emission computed tomography in
post-traumatic stress disorder. Mil Med. 165:473–479.
2000.PubMed/NCBI
|
|
27
|
Pagani M, Högberg G, Salmaso D, et al:
Regional cerebral blood flow during auditory recall in 47 subjects
exposed to assaultive and non-assaultve trauma and developing or
not posttraumatic stress disorder. Eur Arch Psychiatry Clin
Neurosci. 255:359–365. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Francati V, Vermetten E and Bremner JD:
Functional neuroimaging studies in posttraumatic stress disorder:
review of current methods and findings. Depress Anxiety.
24:202–218. 2007. View
Article : Google Scholar
|
|
29
|
Costanzo ES, Sood AK and Lutgendorf SK:
Biobehavioral influences on cancer progression. Immunol Allery Clin
North Am. 31:109–132. 2011. View Article : Google Scholar
|
|
30
|
Mehnert A and Koch U: Prevalence of acute
and post-traumatic stress disorder and comorbid mental disorders in
breast cancer patients during primary cancer care: a prospective
study. Psychooncology. 16:181–188. 2007. View Article : Google Scholar
|
|
31
|
Savitz J and Drevets WC: Bipolar and major
depressive disorder: neuroimaging the developmental-degenerative
divide. Neurosci Biobehav Rev. 33:699–771. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Vodemaier A, Linden W, MacKenzie R, Greig
D and Marshall C: Disease stage predicts post-diagnosis anxiety and
depression only in some types of cancer. Br J Cancer.
105:1814–1817. 2011. View Article : Google Scholar
|
|
33
|
Chiaravalloti A, Danieli R, Abbatiello P,
et al: Factors affecting intrapatient liver and mediastinal blood
pool 18F-FDG standardized uptake value changes during
ABVD chemotherapy in Hodgkin’s lymphoma. Eur J Nucl Med Mol
Imaging. 41:1123–1132. 2014.PubMed/NCBI
|
|
34
|
Wenrib AZ, Sephton SE, Degeest K, et al:
Diurnal cortisol dysregulation, functional disability, and
depression in women with ovarian cancer. Cancer. 116:4410–4419.
2010. View Article : Google Scholar
|
|
35
|
Rich T, Innominato PF, Boerner J, et al:
Elevated serum cytokines correlated with altered behavior, serum
cortisol rhythm and dampene 24-hour rest-activity patterns in
patients with metastatic colorectal cancer. Clin Cancer Res.
11:1757–1764. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lutgendorf SK, Weinrib AZ, Penedo F, et
al: Interleukin-6, cortisol and depressive symptoms on ovarian
cancer patients. J Clin Oncol. 26:4820–4827. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Andersen BL, Kiecolt-Glaser JK and Glaser
R: A biobehavioral model of cancer stress and disease course. Am
Psychol. 49:389–404. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Butler LD, Koopman C, Classen C and
Spiegel D: Traumatic stress, life events, and emotional support in
women with metastatic breast cancer: cancer-related traumatic
stress symptoms associated with past and current stressors. Health
Psychol. 18:555–560. 1999. View Article : Google Scholar
|
|
39
|
Cordova MJ, Studts JL, Hann DM, Jacobsen
PB and Andrykowski MA: Symptom structure of PTSD following breast
cancer. J Trauma Stress. 13:301–319. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
DuHamel KN, Ostrof J, Ashman T, et al:
Construct validity of the posttraumatic stress disorder checklist
in cancer survivors: analyses based on two samples. Psychol Assess.
16:255–266. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Pagani M, Dessi B, Morbelli S, et al: MCI
patients declining and not-declining at mid-term follow-up: FDG-PET
findings. Curr Alzheimer Res. 7:287–294. 2010. View Article : Google Scholar
|
|
42
|
Nobili F, Mazzei D, Dessi B, et al:
Unawareness of memory deficit in amnestic MCI: FDG-PET findings. J
Alzheimers Dis. 22:993–1003. 2012.
|
|
43
|
Del Sole A, Clerici F, Chiti A, et al:
Individual cerebral metabolic deficits in Alzheimer’s disease and
amnestic mild cognitive impairment: an FDG PET study. Eur J Nucl
Med Mol Imaging. 35:1357–1366. 2008. View Article : Google Scholar : PubMed/NCBI
|
